(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpentanoic acid, 98%, 1g

Ethyl 3-fluoro-4-methoxybenzoylformate, 96.0%, 1g

4-Bromo-7-chloro-1H-indazole, 95.0%, 25g

DEFACTINIB, 95%, 25mg

(S)-L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid methyl ester hydrochloride, 98.0%, 10g

Lead(II) Chloride (purified by sublimation) [for Perovskite precursor]>99.5%(T)1g

2-Chloro-4-fluoro-3-methylbenzaldehyde, 95.0%, 1g

2-((2R,3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 97%, 500mg

6-Methoxybenzo[d]thiazole-2-carboxamide, 95.0%, 5g

1-(6-Methylpyridin-2-yl)piperidine-4-carboxylic acid, 250mg

CEFOXITIN, 95%, 25g

6-Chloro-N4-methyl-4,5-pyrimidinediamine, 95.0%, 10g

1H,1'H-2,2'-Biimidazole, 95.0%, 1g